Earnings Call · Q1 FY2022·2022-05-09

Q1 22EPS -4.44%·Rev n/aQ4 21EPS -83.33%·Rev n/aQ3 21EPS +73.91%·Rev n/aQ2 21EPS +100.00%*·Rev n/a⚠ consensus missing

SUPERNUS PHARMACEUTICALS, INC. SUPN

Peter Vozzo — Investor Relations

Jack Khattar — Chief Executive Officer

Tim Dec — Chief Financial Officer

−4.7%1d on move date−3.4% vs SPY3d−10.6%5d−9.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SUPN calls or request research access.

More SUPN calls Browse calls Request research access